Skip to main navigation Skip to search Skip to main content

Combination Antibiotic Therapy Lowers Mortality among Severely III Patients with Pneumococcal Bacteremia

  • Larry M. Baddour
  • , Victor L. Yu
  • , Keith P. Klugman
  • , Charles Feldman
  • , Ake Ortqvist
  • , Jordi Rello
  • , Arthur J. Morris
  • , Carlos M. Luna
  • , David R. Snydman
  • , Chien Ko Wen
  • , M. Bernadete F. Chedid
  • , David S. Hui
  • , Antoine Andremont
  • , Christine C.C. Chiou
  • , Ricardo Mosquera
  • , Carmen De Mier
  • , Angela Famiglietti
  • , Carlos Vay
  • , Jorge Gentile
  • , Monica Sparo
  • Sergio Menna Barreto, Afonso L. Barth, Cicero Dias, Breno Riegel Dos Santos, Karine Grenet, Hyam Mounieme, Margaret Ip, Donald Lyon, Sally A. Roberts, Dragana Drinkovic, Susan L. Taylor, Anne Von Gottberg, Xoliswa Poswa, Rajen Morar, Miquel Gallego, M. Lujan, Emili Diaz, Dolors Mariscal, Dionisia Fontanals, Jose M. Santamaria, Margareta Rylander, Feng Yee Chang, Wen Pin Wu, Chia Yi, Laurie Barefoot, Laura McDermott, David L. Blazes, Gregory Marin, Mandana Mobasseri, Dong Hoon Daniel Kim, John D. Rihs

Research output: Contribution to journalArticlepeer-review

Abstract

Retrospective studies have suggested that combination antibiotic therapy for severe bacteremic pneumococcal pneumonia may reduce mortality. We assessed this issue in a prospective, multicenter, international observational study of 844 adult patients with bacteremia due to Streptococcus pneumoniae. The effect of combination antibiotic therapy versus monotherapy on mortality was examined by univariate analyses and by logistic regression models. The 14-day mortality was not significantly different for the two groups. However, among critically ill patients, combination antibiotic therapy was associated with lower 14-day mortality (23.4 versus 55.3%, p = 0.0015). This improvement in survival was independent of country of origin, intensive care unit support, class of antibiotics, or in vitro activity of the antibiotics prescribed. Combination antibiotic therapy improved survival among critically ill patients with bacteremic pneumococcal illness.

Original languageEnglish
Pages (from-to)440-444
Number of pages5
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume170
Issue number4
DOIs
Publication statusPublished - 2004 Aug 15

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Fingerprint

Dive into the research topics of 'Combination Antibiotic Therapy Lowers Mortality among Severely III Patients with Pneumococcal Bacteremia'. Together they form a unique fingerprint.

Cite this